- XAIR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Beyond Air (XAIR) CORRESPCorrespondence with SEC
Filed: 11 Oct 18, 12:00am
AIT THERAPEUTICS
October 11, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: AIT Therapeutics, Inc. (the “Company”)
Registration Statement on Form S-1
File No. 333-227681
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m. on Friday, October 12, 2018, or as soon thereafter as is practicable.
Very truly yours, | ||
AIT THERAPEUTICS, INC. | ||
By: | /s/ Steven Lisi | |
Steven Lisi | ||
Chief Executive Officer |